logo
Select company
Select metric
$ -1.95MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
32
Sector
72
Industry
88
History
92
$ 2.33Close
$ 1.36 - $ 6.35 52-Week Range
Ticker Information

Ticker

CYCN

Company Name

CYCLERION THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CYCLERION THERAPEUTICS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CYCN - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 0$ -1.95M$ -1.95M
3/31/2025$ 0$ -3.01M$ -3.01M
12/31/2024$ 0$ -3.06M$ -3.06M
9/30/2024$ 0$ -5.52M$ -5.52M
6/30/2024$ 0$ 2.66M$ 2.66M
3/31/2024$ 0$ -197K$ -197K
12/31/2023$ 0$ -5.62M$ -5.62M
9/30/2023$ 0$ -11.17M$ -11.17M
6/30/2023$ 0$ -29.24M$ -29.24M
3/31/2023$ 17K$ -38.43M$ -38.41M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CYCLERION THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA stands at $ -84.77M.
  • Over the past 5 years, CYCLERION THERAPEUTICS INC's average EBITDA has been $ -34.68M.
  • The median EBITDA for CYCLERION THERAPEUTICS INC during this period was $ -41.36M
  • CYCLERION THERAPEUTICS INC reached its highest EBITDA over the past 5 years at $ 2.66M.
  • The lowest EBITDA recorded by CYCLERION THERAPEUTICS INC in the same timeframe $ -84.77M

CYCLERION THERAPEUTICS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
LGVN : LONGEVERON INC $ -17.38MTRAW : TRAWS PHARMA INC $ 87.92MAPRE : APREA THERAPEUTICS INC $ -14.83MXBIO : XENETIC BIOSCIENCES INC $ -3.08MLUCY : INNOVATIVE EYEWEAR INC $ -7.58MLYRA : LYRA THERAPEUTICS INC $ -38.37MVYNE : VYNE THERAPEUTICS INC $ -38.52MSINT : SINTX TECHNOLOGIES INC $ -11.59MSPRB : SPRUCE BIOSCIENCES INC $ -45.81MONCO : ONCONETIX INC $ -43.75M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for CYCLERION THERAPEUTICS INC is calculated as follows: EBIT [ $ -87.25M ] + DepAmor [ $ 2.48M ]
(=) EBITDA [ $ -84.77M ]

CYCN - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -84.77M

Minimum

Sep 30, 2020

$ 2.66M

Maximum

Jun 30, 2024

$ -34.68M

Average

$ -41.36M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.9M
median$ 8.92M
std$ 167.01M